Gilead's coronavirus drug remdesivir will cost over $3,000
Gilead Sciences, the American pharmaceutical company producing a Food and Drug Administration-approved antiviral drug being used to treat severe cases of COVID-19, had agreed to donate its supply of remdesivir through the end of June, but it's now time to put a price on the potentially game-changing medicine — and it won't be cheap.
In the United States, remdesivir will cost $520 per dose, which amounts to more than $3,000 over the course of a typical coronavirus treatment. While that's a lot of money, CNBC reports the price is actually lower than the $5,000 per course some were expecting. Gilead said remdesivir is being offered at a discount "well below value," noting the pandemic requires they do things differently.
The drug will actually be offered at a lower price outside the U.S. Per CNBC, in "other developed countries" the entire course of treatment will cost $2,340, which Gilead says is the result of the way the drug discounting system in the U.S. works.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The Icelandic women’s strike 50 years onIn The Spotlight The nation is ‘still no paradise’ for women, say campaigners
-
Mall World: why are people dreaming about a shopping centre?Under The Radar Thousands of strangers are dreaming about the same thing and no one sure why
-
Why scientists are attempting nuclear fusionThe Explainer Harnessing the reaction that powers the stars could offer a potentially unlimited source of carbon-free energy, and the race is hotting up
-
Nobody seems surprised Wagner's Prigozhin died under suspicious circumstancesSpeed Read
-
Western mountain climbers allegedly left Pakistani porter to die on K2Speed Read
-
'Circular saw blades' divide controversial Rio Grande buoys installed by Texas governorSpeed Read
-
Los Angeles city workers stage 1-day walkout over labor conditionsSpeed Read
-
Mega Millions jackpot climbs to an estimated $1.55 billionSpeed Read
-
Bangladesh dealing with worst dengue fever outbreak on recordSpeed Read
-
Glacial outburst flooding in Juneau destroys homesSpeed Read
-
Scotland seeking 'monster hunters' to search for fabled Loch Ness creatureSpeed Read
